Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × Busulfan × Clear all

Phase

Status

Completed 5 Terminated 2 Recruiting 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 15 Leukemia, Myeloid, Acute 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Multiple Myeloma 6 Myelodysplastic Syndromes 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Neuroblastoma 4 Hodgkin Disease 4 Graft vs Host Disease 4 Congenital Abnormalities 4 Recurrence 3 Neoplasms, Plasma Cell 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Follicular 3 Leukemia, Myelomonocytic, Juvenile 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Burkitt Lymphoma 3 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Myeloid, Accelerated Phase 2

Interventions

Exercise 18 Drug Therapy 16 pembrolizumab 11 Surveys and Questionnaires 11 Capecitabine 11 Blood Specimen Collection 11 Radiotherapy 10 Dexamethasone 9 Paclitaxel 8 Standard of Care 7 Oxaliplatin 7 Nivolumab 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Control Groups 5 Biopsy 5 Bevacizumab 5 sintilimab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00750126 2011-01-19

RICE

University Hospital, Clermont-Ferrand

Phase 2 Unknown

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡